Skip to main navigation
Skip to search
Skip to main content
WashU Research Profiles Home
Help & FAQ
Link opens in a new tab
Search content at WashU Research Profiles
Home
Profiles
Research units
Research output
Management of chronic lymphocytic leukemia: An update
Matthew Kaufman
, Jian Li Campian
, Kanti R. Rai
Section of Medical Oncology
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Management of chronic lymphocytic leukemia: An update'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Neuroscience
Monoclonal Antibody
100%
Rituximab
100%
Alemtuzumab
100%
CD20
100%
Purine
100%
CD52
100%
Keyphrases
Chronic Lymphocytic Leukemia
100%
Monoclonal Antibody
25%
Rituximab
25%
Therapeutic Potential
25%
Prognostic Marker
25%
Disease Course
25%
Alemtuzumab
25%
CD20
25%
Most Common Form
25%
Western World
25%
Adult Leukemia
25%
Lymphocytosis
25%
Routine Blood Test
25%
Purine Analogues
25%
Anti-CD52
25%
Immunology and Microbiology
Monoclonal Antibody
100%
CD20
100%
Rituximab
100%
Alemtuzumab
100%
Medicine and Dentistry
B-Cell Chronic Lymphocytic Leukemia
100%
Monoclonal Antibody
25%
Disease Course
25%
Rituximab
25%
CD20
25%
Leukemia
25%
Lymphocytosis
25%
Alemtuzumab
25%
Purine
25%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Lymphatic Leukemia
100%
Leukemia
25%
Rituximab
25%
Monoclonal Antibody
25%
Disease Course
25%
Purine Derivative
25%
Purine
25%
Alemtuzumab
25%
Lymphocytosis
25%